Cargando…
MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors
BACKGROUND: Contemporary challenges of prostate cancer (PCa) include overdiagnosis and overtreatment, entailing the need for novel clinical tools to improve risk stratification and therapy selection. PCa diagnosis and prognostication might be perfected using epigenetic biomarkers, among which aberra...
Autores principales: | Torres-Ferreira, Jorge, Ramalho-Carvalho, João, Gomez, Antonio, Menezes, Francisco Duarte, Freitas, Rui, Oliveira, Jorge, Antunes, Luís, Bento, Maria José, Esteller, Manel, Henrique, Rui, Jerónimo, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282784/ https://www.ncbi.nlm.nih.gov/pubmed/28143614 http://dx.doi.org/10.1186/s12943-017-0604-0 |
Ejemplares similares
-
Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer
por: Ramalho-Carvalho, João, et al.
Publicado: (2017) -
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
por: Chim, Chor Sang, et al.
Publicado: (2011) -
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma
por: Grossi, Ilaria, et al.
Publicado: (2016) -
Upregulation of miR‐9 and miR‐193b over human Th17 cell differentiation
por: Shirani, Fahimeh, et al.
Publicado: (2020) -
MiR‐193b deregulation is associated with Parkinson's disease
por: Baghi, Masoud, et al.
Publicado: (2021)